Marathon Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Marathon Capital Management's MDT Position: Q3 2026 in Review
Marathon Capital Management increased its Medtronic (MDT) stake by 1.6% in Q3 2026, buying an estimated $15.6K and bringing the position to 11,534 shares worth $995K. The position accounts for 0.2% of the portfolio, ranked #77.
Marathon Capital Management first reported a position in MDT in Q2 2013 and has held it in 15 quarters since. 2,192 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Marathon Capital Management held 11,534 shares of Medtronic worth $995K as of Q3 2026.
- Marathon Capital Management bought 177 Medtronic shares in Q3 2026, an estimated $15.6K.
- Medtronic made up 0.2% of Marathon Capital Management's portfolio in Q3 2026, its #77 holding.
- Marathon Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 15 quarters since.
- 2,192 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Marathon Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.